Notice Number: NOT-DA-19-054
Release Date: July 05, 2019
Response Date: September 01, 2019
National Institute on Drug Abuse (NIDA)
National Institute on Aging (NIA)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
This RFI seeks input from stakeholders throughout the scientific research and medical education community and the general public regarding the CoEPEs program, general pain education, opioid misuse or use disorder education curriculum. Stakeholders of interest include but are not limited to: health care professionals providing pain treatment, students in medical, dental and nursing schools, residents, fellows, teaching faculty, medical and dental associations, and education accrediting agencies.
Chronic pain affects about 100 million American adults and costs the nation up to $635 billion each year in medical treatment and lost productivity. In response to this public health concern and the 2011 Institute of Medicine report on “Relieving Pain in America,” the Department of Health and Human Services (DHHS) created the National Pain Strategy (NPS). Among many priorities and recommendations outlined in the NPS, the plan identified a need to educate health care professionals on pain, pain treatment, and its interaction with opioid misuse and use disorder. Specifically, the NPS recommended steps to improve discipline-specific core competencies, including basic knowledge, assessment, effective team-based care, empathy, and cultural competency. The plan encouraged educational program accreditation bodies and professional licensure boards to require pain teaching and clinician learning at the undergraduate, graduate, residency and continuous education levels. The NPS also endorsed the development of a web-based pain education portal that would contain up-to-date, comprehensive, and easily accessed educational materials. These training efforts should be made in coordination with current DHHS efforts to develop tools for providers to recognize the risk factors and symptoms of opioid use disorders.
The National Institute of Health (NIH) Pain Consortium was established to enhance pain research and promote collaboration among researchers across the many NIH Institutes and Centers that have programs and activities addressing pain. In line with the education recommendations outlined in the NPS, the Pain Consortium created and supports the Centers of Excellence in Pain Education (CoEPEs; https://painconsortium.nih.gov/Funding_Research/CoEPEs). CoEPEs act as hubs for the development, evaluation, and distribution of pain management curriculum resources for medical, dental, nursing, pharmacy and other schools to enhance and improve how health care professionals are taught about pain and its treatment. These modules are intended to educate health care professionals on the different types of pain resulting from various forms of surgery, pain conditions, comorbidities, acute and chronic pain treatment, and opioid use disorder.
This RFI seeks input from stakeholders throughout the scientific research and medical education community and the general public regarding the CoEPEs program, general pain, opioid misuse and opioid use disorder education curriculum. Stakeholders of interest include but are not limited to: health care professionals providing pain treatment, students in medical, dental, pharmacy, physical therapy and nursing schools, residents, fellows, teaching faculty, medical associations, physical therapy and occupational therapy associations and education accrediting agencies.
The NIH seeks information in response to any or all of the following topics of interest:
How to Submit a Response:
Responses to this RFI will be accepted through September 1, 2019.
Responses to this RFI must be submitted electronically via email to: email@example.com
Responses to this RFI are voluntary. Do not include any proprietary, classified, confidential, trade secret, or sensitive information in your response. The responses will be reviewed by NIH staff, and individual feedback will not be provided to any responder. The Government will use the information submitted in response to this RFI at its discretion. The Government reserves the right to use any submitted information on public NIH websites, in reports, in summaries of the state of the science, in any possible resultant solicitation(s), grant(s), or cooperative agreement(s), or in the development of future funding opportunity announcements.
This RFI is for information and planning purposes only and shall not be construed as a solicitation, grant, or cooperative agreement, or as an obligation on the part of the Federal Government, the NIH, or individual NIH Institutes and Centers to provide support for any ideas identified in response to it. The Government will not pay for the preparation of any information submitted or for the Government’s use of such information. No basis for claims against the U.S. Government shall arise because of a response to this request for information or from the Government’s use of such information. NIH looks forward to your input and we hope that you will share this RFI document with your colleagues.
Please direct all inquiries to:
Shelley Su, PhD
National Institute on Drug Abuse